Global Gastrointestinal Endoscopy Devices Market Size By Type (GI Videoscopes, ERCP), By Application (Hospitals and Clinics, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Gastrointestinal Endoscopy Devices Market was valued at USD 6.3 billion in 2023 and is projected to reach USD 11.1 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. This growth is driven by the rising prevalence of gastrointestinal disorders, increasing geriatric population, growing preference for minimally invasive procedures, and advancements in endoscopic technology. Gastrointestinal (GI) endoscopy devices play a critical role in diagnosing and treating disorders across the GI tract, including ulcers, cancers, polyps, and inflammatory bowel diseases. Technological innovations such as capsule endoscopy, HD imaging, and robotic-assisted endoscopy are transforming the diagnostics landscape, making procedures safer and more accurate.

Drivers

Rising Incidence of GI Disorders:

The growing global burden of gastrointestinal diseases, including colorectal cancer, GERD, and Crohn’s disease, is one of the primary factors propelling the demand for GI endoscopy devices. Early diagnosis facilitated by endoscopy significantly improves patient outcomes.

Preference for Minimally Invasive Procedures:

Endoscopic procedures are less invasive than traditional surgeries, offer faster recovery, and reduce hospital stays. This preference is boosting the adoption of GI endoscopy devices in both outpatient and inpatient settings.

Technological Advancements:

Continuous innovation in GI endoscopic technologies—such as the advent of AI-enabled endoscopy, improved image resolution, and single-use scopes—enhances diagnostic precision and expands the scope of endoscopic interventions.

Restraints

High Equipment Cost and Maintenance:

The cost of acquiring and maintaining advanced endoscopy systems remains high, especially for small-scale healthcare providers in developing regions, posing a barrier to market penetration.

Risk of Infection and Complications:

Despite being minimally invasive, endoscopic procedures carry a risk of complications, such as bleeding or perforation, and require stringent sterilization protocols to prevent infection transmission.

Opportunity

Expanding Healthcare Access in Emerging Markets:

Developing economies, especially in Asia-Pacific and Latin America, are witnessing improvements in healthcare infrastructure and growing awareness about early disease diagnosis, offering significant market expansion opportunities.

Integration of Artificial Intelligence (AI):

AI-powered endoscopy systems capable of detecting polyps and other abnormalities in real-time are revolutionizing diagnostics, offering a compelling growth avenue for market players.

Market by System Type Insights

The Flexible Endoscopes segment held the dominant market share in 2023, attributed to their ease of navigation, patient comfort, and widespread usage in diagnostic and therapeutic procedures across the GI tract. However, the Capsule Endoscopy segment is expected to grow at the fastest pace due to its non-invasive nature and ability to examine hard-to-reach areas, particularly in the small intestine.

Market by End-use Insights

Hospitals emerged as the largest end-user segment in 2023, accounting for over 50% of the market share. Their well-equipped infrastructure, access to skilled endoscopists, and high patient volume make them the primary centers for GI endoscopic procedures. Ambulatory Surgical Centers (ASCs) are expected to gain traction due to the growing preference for outpatient endoscopic procedures that offer convenience and cost-efficiency.

Market by Regional Insights

North America led the market in 2023, driven by advanced healthcare systems, high adoption of innovative technologies, and increasing incidence of GI cancers. Asia-Pacific is anticipated to be the fastest-growing region through 2031, fueled by an aging population, rising healthcare expenditure, and increased awareness of early screening in countries like China, Japan, and India.

Competitive Scenario

Major players in the Global Gastrointestinal Endoscopy Devices Market include Olympus Corporation, Medtronic plc, Fujifilm Holdings Corporation, Boston Scientific Corporation, Pentax Medical, CONMED Corporation, Karl Storz SE & Co. KG, Ambu A/S, and Cook Medical. These companies are actively engaged in strategic collaborations, product launches, and regional expansion to enhance their market position.

Scope of Work – Global Gastrointestinal Endoscopy Devices Market

Report Metric Details

Market Size (2023) USD 6.3 Billion

Projected Market Size (2031) USD 11.1 Billion

CAGR (2023–2031) 7.3%

Market Segments By System Type (Flexible Endoscopes, Capsule Endoscopy), By End-use (Hospitals, ASCs), By Region

Growth Drivers Rising prevalence of GI diseases, Preference for minimally invasive procedures, Technological advancements

Opportunities Emerging markets, AI-powered endoscopy innovations